Mantle Cell Lymphoma (MCL) Completed Phase 2 Trials for Cyclophosphamide (DB00531)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00490529Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCLTreatment
NCT00581776Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell LymphomaTreatment
NCT00022945Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell LymphomaTreatment
NCT00285389Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 YearsTreatment
NCT00958256Study of Bortezomib in Combination With Cyclophosphamide and RituximabTreatment